SEC Form 4 · accession 0001189727-18-000010

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Alison D Burcar

Officer — Vice President and Gen'l Mgr.

Period of report

Jun 18, 2018

Accepted (ET)

Jun 20, 2018 · 6:14 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 18, 2018	X	17,108	$58.79	A	21,311	D
Common Stock^F1,F2	Jun 18, 2018	S	1,700	$302.93	D	19,611	D
Common Stock^F1,F3	Jun 18, 2018	S	1,800	$304.16	D	17,811	D
Common Stock^F1,F4	Jun 18, 2018	S	412	$304.73	D	17,399	D
Common Stock^F1,F5	Jun 18, 2018	S	100	$305.90	D	17,299	D
Common Stock^F5	Jun 18, 2018	S	191	$305.90	D	17,108	D
Common Stock^F7	Jun 18, 2018	S	7,199	$301.56	D	9,909	D
Common Stock^F8	Jun 18, 2018	S	5,735	$302.75	D	4,174	D
Common Stock^F9	Jun 18, 2018	S	1,977	$303.40	D	2,197	D
Common Stock^F10	Jun 18, 2018	S	2,197	$304.65	D	0	D
Common Stock	Jun 19, 2018	X	34,747	$58.79	A	34,747	D
Common Stock^F11	Jun 19, 2018	S	2,500	$300.20	D	32,247	D
Common Stock^F12	Jun 19, 2018	S	26,973	$301.84	D	5,274	D
Common Stock^F13	Jun 19, 2018	S	5,274	$302.27	D	0	D
Common Stock	Jun 20, 2018	X	21,169	$58.79	A	21,169	D
Common Stock^F14	Jun 20, 2018	S	5,294	$300.73	D	15,875	D
Common Stock^F15	Jun 20, 2018	S	13,750	$301.66	D	2,125	D
Common Stock^F5	Jun 20, 2018	S	2,125	$302.50	D	0	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F17,F16	$58.79	Jun 18, 2018	X	17,108	D	—	Feb 24, 2024	Common Stock	17,108	57,892	D
Non-Qualified Stock Option (right to buy)^F17,F16	$58.79	Jun 19, 2018	X	34,747	D	—	Feb 24, 2024	Common Stock	34,747	23,145	D
Non-Qualified Stock Option (right to buy)^F17,F16	$58.79	Jun 20, 2018	X	21,169	D	—	Feb 24, 2024	Common Stock	21,169	1,976	D

Explanation of responses

F1These securities are Restricted Stock Units.
F10The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.15 to $305.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F11The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.55, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F12The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.10 to $302.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F13The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.13 to $302.40, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F14The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.20 to $301.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F15The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.30 to $302.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F16Options exercisable in four equal annual cumulative installments commencing one year after the grant date.
F17Transaction is the exercise of a derivative security; see Column 2.
F2The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.50 to $303.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.55 to $304.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.60 to $304.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5All shares sold were sold at the exact price disclosed.
F6Shares were previously acquired through the Registrant's Employee Stock Purchase Plan.
F7The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F8The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.05 to $303.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F9The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.10 to $304.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Remarks

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2018.